E-Articles - Health and Fitness

Telogen effluvium is an abnormal loss of hair arising from alteration of the

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

normal hair growth cycles. It is considered as a prominent alopecia cause. Ho

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ever, it is a poorly defined condition with very little research been done to

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

understand this disease.

There can be various factors causing alteration of

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

the normal hair cycle. In general most of the hairs are in the growth stage a

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

d only around one hundred hairs fall from the scalp each day.

Te problem wit

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

nesses a higher proportion of the hairs entering the resting phase of the cyc

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

e and hair shedding is greater than normal.

There are varied cures for Telog

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

n Effluvium. Some causes are temporary, and there is hair regrowth after a sh

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ort period of time. And there are other causes that are more persistent and c

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

nsequently the hair loss continues. You can divide the causes into three type

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

– a.) General causes, b.) Inadequate diet, c.) Stress.

The common diseases

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

that cause alopecia include telogen effluvium or anagen effluvium. Both these

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

effluviums are reversible to a large extent, as cures for telogen effluvium a

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

d anagen effluvium both are there. Once the triggering causes are removed, th

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ese hair loss problems gradually subside. Anagen effluvium is caused by stron

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

cancer therapies and treatments. Once the treatment courses for cures of tel

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

gen effluvium are completed, hair resumes its normal growth. In some cases, t

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

elogen effluvium is chronic and can cause severe thinning of hair. Proper dia

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

nosis and regular medications will help you bring cures for telogen effluvium

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/248416/e-article-Cures-For-Telogen-Effluvium.html">Cures For Telogen Effluvium</a>

BB link (for phorums):
[url=http://www.e-article.org.ua/article/248416/e-article-Cures-For-Telogen-Effluvium.html]Cures For Telogen Effluvium[/url]

Why do you want a website? If your a business owner are you building a website just because everyone else seems to be? or do you have a plan for it? Many websites fail to simply because they lacked a plan or more simply because the owner didn't have a real purpose for the site.

Interesting overview and introduction into Technical Analysis... The methods used to analyze securities (stocks) and make investment decisions are vast, but tend to fall into one of two categories known as fundamental analysis and technical analysis. Fundamental analysis involves...

The Internet marketing article is an extremely powerful promotional and selling tool. However you require a clear plan and course of action. You especially need to know what your conversion rate is.

Tags

Links

E-Articles - Cures For Telogen Effluvium

Related Articles: